Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14

Abstract
Aims Abciximab has previously been shown to enhance thrombolysis and improve myocardial perfusion when combined with reduced doses of alteplase. The

This publication has 0 references indexed in Scilit: